Refine by
Myocardial Infarction Suppliers & Manufacturers
3 companies found
Technologybased inLabège, FRANCE
Vaiomer microbiome studies and expert service supports your discoveries and innovations when identifying predictors and mechanisms associated with the development of chronic diseases. Vaiomer challenges the frontiers of microbiome research by ...
Technologybased inFrankfurt am Main, GERMANY
We are leaders in therapeutic target discovery and RNA-targeted therapies in cardiovascular and cardiometabolic disease. Our technology platforms seamlessly integrate synergistically to accelerate development of RNAi therapies to treat illnesses ...
Loss of cardiomyocytes (heart cells) is the primary hallmark of heart failure. However, unlike other cell types, there is a limited capacity for cardiomyocytes proliferation in the adult heart and in the failing human heart. Therefore, regenerative ...
Technologybased inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...